Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

109 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The relationship between environmental factors and different Parkinson's disease subtypes in Greece: Data analysis of the Hellenic Biobank of Parkinson's disease.
Angelopoulou E, Bozi M, Simitsi AM, Koros C, Antonelou R, Papagiannakis N, Maniati M, Poula D, Stamelou M, Vassilatis DK, Michalopoulos I, Geronikolou S, Scarmeas N, Stefanis L. Angelopoulou E, et al. Parkinsonism Relat Disord. 2019 Oct;67:105-112. doi: 10.1016/j.parkreldis.2019.08.013. Epub 2019 Aug 26. Parkinsonism Relat Disord. 2019. PMID: 31494049
Serum Uric Acid Level as a Biomarker in Idiopathic and Genetic (p.A53T Alpha-Synuclein Carriers) Parkinson's Disease: Data from the PPMI Study.
Koros C, Simitsi AM, Papadimitriou D, Bougea A, Prentakis A, Papagiannakis N, Pachi I, Bozi M, Antonelou R, Angelopoulou E, Beratis I, Papageorgiou SG, Trapali XG, Stamelou M, Stefanis L. Koros C, et al. Among authors: angelopoulou e. J Parkinsons Dis. 2020;10(2):481-487. doi: 10.3233/JPD-191860. J Parkinsons Dis. 2020. PMID: 32176655
Serum uric acid level as a putative biomarker in Parkinson's disease patients carrying GBA1 mutations: 2-Year data from the PPMI study.
Koros C, Simitsi AM, Papagiannakis N, Bougea A, Prentakis A, Papadimitriou D, Pachi I, Antonelou R, Angelopoulou E, Beratis I, Bozi M, Papageorgiou SG, Trapali XG, Stamelou M, Stefanis L. Koros C, et al. Among authors: angelopoulou e. Parkinsonism Relat Disord. 2021 Mar;84:1-4. doi: 10.1016/j.parkreldis.2020.12.020. Epub 2021 Jan 20. Parkinsonism Relat Disord. 2021. PMID: 33508700 Free article.
Serum Uric Acid in LRRK2 Related Parkinson's Disease: Longitudinal Data from the PPMI Study.
Bougea A, Koros C, Papagiannakis N, Simitsi AM, Prentakis A, Papadimitriou D, Pachi I, Antonelou R, Angelopoulou E, Beratis I, Bozi M, Papageorgiou SG, Trapali XG, Stamelou M, Stefanis L. Bougea A, et al. Among authors: angelopoulou e. J Parkinsons Dis. 2021;11(2):633-640. doi: 10.3233/JPD-202337. J Parkinsons Dis. 2021. PMID: 33682725
Apathy: An underestimated feature in GBA and LRRK2 non-manifesting mutation carriers.
Pachi I, Koros C, Simitsi AM, Papadimitriou D, Bougea A, Prentakis A, Papagiannakis N, Bozi M, Antonelou R, Angelopoulou E, Beratis I, Stamelou M, Trapali XG, Papageorgiou SG, Stefanis L. Pachi I, et al. Among authors: angelopoulou e. Parkinsonism Relat Disord. 2021 Oct;91:1-8. doi: 10.1016/j.parkreldis.2021.08.008. Epub 2021 Aug 18. Parkinsonism Relat Disord. 2021. PMID: 34425330
Clinical differences between early-onset and mid-and-late-onset Parkinson's disease: Data analysis of the Hellenic Biobank of Parkinson's disease.
Angelopoulou E, Bozi M, Simitsi AM, Koros C, Antonelou R, Papagiannakis N, Maniati M, Poula D, Stamelou M, Vassilatis DK, Michalopoulos I, Geronikolou S, Scarmeas N, Stefanis L. Angelopoulou E, et al. J Neurol Sci. 2022 Nov 15;442:120405. doi: 10.1016/j.jns.2022.120405. Epub 2022 Sep 2. J Neurol Sci. 2022. PMID: 36081304
109 results